Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTRN12610000531011Phase 4Not yet recruiting
Phase 4, randomised, double-blind trial of mepivacaine and lidocaine in ingrown nail (2 arms), sponsored by Mr Priten Solanki. Primary endpoint: Pain measured by Visual Analogue Scale. Planned start Aug 2010; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ACTRN12610000531011.